Romix Biosciences

New York, United States

Accelerating drug development with an AI-enabled full body molecular scan of inflammation

$600K raised

Jul 2025

Pre-Seed

Biotechnology Market Research

Top Investors

2048 Ventures ARC Capital Management

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Romix Biosciences

How much funding has Romix Biosciences raised?

Romix Biosciences has raised $600K in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2025.

Who are Romix Biosciences's investors?

Romix Biosciences's investors include 2048 Ventures, ARC Capital Management.

Where is Romix Biosciences headquartered?

Romix Biosciences is headquartered in New York, United States.

What does Romix Biosciences do?

Accelerating drug development with an AI-enabled full body molecular scan of inflammation

What stage is Romix Biosciences at?

Romix Biosciences is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 30, 2025.

MLA

"Romix Biosciences — Funding & Investors." VCBacked, July 30, 2025, https://www.vcbacked.co/company/romix-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2025). Romix Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/romix-biosciences

Wikipedia (cite web)

{{cite web |title=Romix Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/romix-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 30, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K